Skip to content

SeQuent Scientific zooms 14% on terminating Tineta Pharma acquisition

The stock has corrected over 79.4 percent from its lifetime highs tested in July 2021.

Read More

​ The stock has corrected over 79.4 percent from its lifetime highs tested in July 2021. The stock has corrected over 79.4 percent from its lifetime highs tested in July 2021.  Moneycontrol Latest News Read More  

Leave a Reply

Your email address will not be published. Required fields are marked *

en_USEnglish